# UAB Diabetes Research Center

> **NIH NIH P30** · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2022 · $1,245,082

## Abstract

This proposal will continue progress of the UAB DRC first established in 2008. Our mission is: “Alleviate
suffering and the social burden caused by diabetes and cardiometabolic disease through innovative,
multidisciplinary, basic and translational research and research training, which advances understanding of
disease mechanisms, prevention, and treatment”. Over 9 years, the DRC has galvanized the UAB research
community around the study of diabetes resulting in increased membership by 69% from 115 to 194 and an
increase in active extramural diabetes research funding to a total of $62,427,510 annual direct costs. Our
center’s goals are to facilitate excellence in diabetes research, further develop a cohesive intellectual
community promoting collaboration and innovation, and provide an outstanding environment for training and
career development. Our research emphasizes the study of diabetes as both a metabolic and vascular disease
and includes areas of research excellence including molecular signaling, islet biology & autoimmunity,
integrative metabolism vascular disease/inflammation, diabetes complications, genetics & epidemiology, and
interventions & community based research. Our specific aims are to:
 1. Facilitate and enhance diabetes research by sponsoring research core facilities expressly required by our
investigator base and that cover a broad translational spectrum: Bioanalytical REDOX Biology, Animal
Physiology, Human Physiology, and Interventions & Translation Cores.
 2. Augment diabetes research via a pilot & feasibility grant program that will emphasize innovation,
translation, and career development of highly promising junior investigators.
 3. Sponsor an integrated Enrichment Program that promotes a cohesive environment for an outstanding
multi-disciplinary investigator base, which will enhance learning, collaboration, collegiality, and innovation.
 4. Emphasize research, training, and outreach that are responsive to the needs of our trainees, achieve
better outcomes for our patients, and lessen the high burden of diabetes in our community and nation.
 5. Respond to the evolving needs of our investigators and through leadership that impels new ideas and
lines of investigation, and leverage the resolve of UAB leadership, substantial institutional commitments, and
generous philanthropy from our community to further impel the development of a pre-eminent center of
diabetes research excellence in the heart of the Deep South.
 The DRC has exerted a pronounced impact on diabetes research excellence at UAB in a community with
the highest rates of diabetes in the US, and has united investigators around common themes to study diabetes
in the context of cardiometabolic disease. We are confident that further evolution and growth will be achieved
over the next 5 years.

## Key facts

- **NIH application ID:** 10485935
- **Project number:** 5P30DK079626-15
- **Recipient organization:** UNIVERSITY OF ALABAMA AT BIRMINGHAM
- **Principal Investigator:** W Timothy GARVEY
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,245,082
- **Award type:** 5
- **Project period:** 2008-04-01 → 2023-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10485935

## Citation

> US National Institutes of Health, RePORTER application 10485935, UAB Diabetes Research Center (5P30DK079626-15). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10485935. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*